Diagnostic  competence of Swiss general practitioners in skin cancer

Nina Badertscher; Ralph P Braun; Ulrike Held; Reto Kofmehl; Oliver Senn; Günther FL Hofbauer; Pascal O Rossi; Michel JP Wensing; Thomas Rosemann; Ryan Tandjung

doi:10.4414/smw.2013.13834

Original article

Vol. 143 No. 3132 (2013)

Diagnostic competence of Swiss general practitioners in skin cancer

Nina Badertscher
Ralph P Braun
Ulrike Held
Reto Kofmehl
Oliver Senn
Günther FL Hofbauer
Pascal O Rossi
Michel JP Wensing
Thomas Rosemann
Ryan Tandjung

DOI: https://doi.org/10.4414/smw.2013.13834
Cite this as:: Swiss Med Wkly. 2013;143:w13834
Published: 28.07.2013

References

Bouchardy C, Lutz JM, Kühni C. Cancer in Switzerland. Situation and Development from 1983 up to 2007. http://www.nicer.org/Editor/files/Krebs_in_der_Schweiz_e_web.pdf. http://www.nicer.org/Editor/files/Krebs_in_der_Schweiz_e_web.pdf In.; 2011.
Lutz JM, Francisci S, Mugno E, Usel M, Pompe-Kirn V, Coebergh JW, Bieslka-Lasota M. Cancer prevalence in Central Europe: the EUROPREVAL Study. Ann Oncol. 2003;14(2):313–22.
de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004;40(16):2355–66.
de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107(1):119–26.
Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27(1):3–9.
Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012;167(5):1124–30.
Dummer R, Panizzon R, Bloch PH, Burg G. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology. 2005;210(1):39–44.
Dummer R, Guggenheim M, Arnold AW, Braun R, von Moos R. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly. 2011;141:w13320.
Switzerland - Statistics of Cancer Incidence [http://www.nicer.org/assets/files/statistics/i5y8409ch.pdf]
Reinau D, Meier C, Gerber N, Hofbauer GF, Surber C. Sun protective behaviour of primary and secondary school students in North-Western Switzerland. Swiss Med Wkly. 2012;142:w13520.
Gass R, Bopp M: [Mortality from malignant melanoma: epidemiological trends in Switzerland]. Praxis. (Bern 1994) 2005;94(34):1295–300.
Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jockel KH. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol. 2008;22(1):65–72.
Badertscher N, Rosemann T, Tandjung R, Braun RP. minSKIN does a multifaceted intervention improve the competence in the diagnosis of skin cancer by general practitioners? Study protocol for a randomised controlled trial. Trials. 2011;12:165.
[http://aerztestatistik.myfmh2.fmh.ch/]
Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. J Am Acad Dermatol. 2001;44(6):979–86.
De Gannes GC, Ip JL, Martinka M, Crawford RI, Rivers JK. Early detection of skin cancer by family physicians: A pilot project. J Cutan Med Surg. 2004;8(2):103–9.
Gerbert B, Bronstone A, Wolff M, Maurer T, Berger T, Pantilat S, McPhee SJ. Improving primary care residents’ proficiency in the diagnosis of skin cancer. J Gen Intern Med. 1998;13(2):91–7.
Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen. 1996;3(1):47–53.
Raasch BA, Hays R, Buettner PG: An educational intervention to improve diagnosis and management of suspicious skin lesions. J Contin Educ Health Prof. 2000;20(1):39–51.
Westerhoff K, McCarthy WH, Menzies SW. Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol. 2000;143(5):1016–20.
Youl PH, Raasch BA, Janda M, Aitken JF. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions. Clin Exp Dermatol. 2007;32(4):365–70.

How to Cite

1.

Badertscher N, Braun R, Held U, Kofmehl R, Senn O, Hofbauer G, Rossi P, Wensing M, Rosemann T, Tandjung R. Diagnostic competence of Swiss general practitioners in skin cancer. Swiss Med Wkly [Internet]. 2013 Jul. 28 [cited 2025 Feb. 12];143(3132):w13834. Available from: https://smw.ch/index.php/smw/article/view/1716

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Lacher Simone, Albert Wettstein, Oliver Senn, Thomas Rosemann, Susann Hasler, Types of abuse and risk factors associated with elder abuse , Swiss Medical Weekly: Vol. 146 No. 0304 (2016)
Stefan Neuner-Jehle, Thomas Grischott, Stefan Markun, Marc Maeder, Thomas Rosemann, Oliver Senn, What interventions do general practitioners recommend avoiding? A nationwide survey from Switzerland , Swiss Medical Weekly: Vol. 150 No. 2526 (2020)
Lisa Jungblut, Christophe von Garnier, Milo Puhan, Yuki Tomonaga, Cornel Kaufmann, Andrea Azzola, Urs Bürgi, Jens Bremerich, Martin Brutsche, Andreas Christe, Lukas Ebner, Johannes T Heverhagen, Christine Eich, Daniel Franzen, Isabelle Schmitt-Opitz, Didier Schneiter, Jörg Spieldenner, Nigel Horwarth, Malcolm Kohler, Walter Weder, Alban Lovis, Reto Meuli, Matthias Menig, Catherine Beigelmann-Aubry, Tilo Niemann, Susanna Stöhr, Peter Vock, Oliver Senn, Stefan Neuner-Jehle, Kevin Selby, Simin Laures, Sebastian Ott, Thomas Frauenfelder, The Swiss Approach – feasibility of a national low-dose CT lung cancer screening program , Swiss Medical Weekly: Vol. 152 No. 1516 (2022)
Christian Mueller, Klaus Bally, Marc Buser, Andreas J. Flammer, Jean-Michel Gaspoz, François Mach, Giorgio Moschovitis, Matthias Paul, Andreas Zeller, Ellen Heitlinger, Bianca Fay, Thomas Rosemann, Roadmap for the treatment of heart failure patients after hospital discharge: an interdisciplinary consensus paper , Swiss Medical Weekly: Vol. 150 No. 0506 (2020)
Rosario Agosti-Gonzalez, Luis Falcato, Thomas Grischott, Oliver Senn, Philip Bruggmann, Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study , Swiss Medical Weekly: Vol. 153 No. 6 (2023)
Rahel Meier, Thomas Grischott, Yael Rachamin, Levy Jäger, Oliver Senn, Thomas Rosemann, Jakob M. Burgstaller, Stefan Markun, Importance of different electronic medical record components for chronic disease identification in a Swiss primary care database: a cross-sectional study , Swiss Medical Weekly: Vol. 153 No. 10 (2023)
Nahara Anani Martínez-González, Andreas Plate, Oliver Senn, Stefan Markun, Thomas Rosemann, Stefan Neuner-Jehle, Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials , Swiss Medical Weekly: Vol. 148 No. 0708 (2018)
Yael Rachamin, Sofia Elena Nerlich, Levy Jäger, Saskia Maria De Gani, Olivier Favre, Oliver Senn, Adolescents’ self-reported health status, behaviours and health issues addressed during routine school doctor consultations in Switzerland: an observational study , Swiss Medical Weekly: Vol. 153 No. 5 (2023)
Rahel Meier, Ellen Keizer, Thomas Rosemann, Stefan Markun, Indications and associated factors for prescribing intravenous iron supplementation in Swiss general practice: a retrospective observational study , Swiss Medical Weekly: Vol. 149 No. 3738 (2019)
Christina Hempel-Bruder, Lamprini Syrogiannouli, Rémi Schneider, Sarah Bissig, Oliver Senn, Kali Tal, Jean-Luc Bulliard, Cyril Ducros, Christian P. R. Schmid, Reto Auer, Kevin Selby, Colorectal cancer testing rates after implementation of an organised screening programme in Vaud, Switzerland , Swiss Medical Weekly: Vol. 153 No. 4 (2023)

1 2 3 4 > >>

[1] Bouchardy C, Lutz JM, Kühni C. Cancer in Switzerland. Situation and Development from 1983 up to 2007. http://www.nicer.org/Editor/files/Krebs_in_der_Schweiz_e_web.pdf. http://www.nicer.org/Editor/files/Krebs_in_der_Schweiz_e_web.pdf In.; 2011.

[2] Lutz JM, Francisci S, Mugno E, Usel M, Pompe-Kirn V, Coebergh JW, Bieslka-Lasota M. Cancer prevalence in Central Europe: the EUROPREVAL Study. Ann Oncol. 2003;14(2):313–22.

[3] de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004;40(16):2355–66.

[4] de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107(1):119–26.

[5] Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27(1):3–9.

[6] Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012;167(5):1124–30.

[7] Dummer R, Panizzon R, Bloch PH, Burg G. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology. 2005;210(1):39–44.

[8] Dummer R, Guggenheim M, Arnold AW, Braun R, von Moos R. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly. 2011;141:w13320.

[9] Switzerland - Statistics of Cancer Incidence [http://www.nicer.org/assets/files/statistics/i5y8409ch.pdf]

[10] Reinau D, Meier C, Gerber N, Hofbauer GF, Surber C. Sun protective behaviour of primary and secondary school students in North-Western Switzerland. Swiss Med Wkly. 2012;142:w13520.

[11] Gass R, Bopp M: [Mortality from malignant melanoma: epidemiological trends in Switzerland]. Praxis. (Bern 1994) 2005;94(34):1295–300.

[12] Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jockel KH. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol. 2008;22(1):65–72.

[13] Badertscher N, Rosemann T, Tandjung R, Braun RP. minSKIN does a multifaceted intervention improve the competence in the diagnosis of skin cancer by general practitioners? Study protocol for a randomised controlled trial. Trials. 2011;12:165.

[14] [http://aerztestatistik.myfmh2.fmh.ch/]

[15] Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. J Am Acad Dermatol. 2001;44(6):979–86.

[16] De Gannes GC, Ip JL, Martinka M, Crawford RI, Rivers JK. Early detection of skin cancer by family physicians: A pilot project. J Cutan Med Surg. 2004;8(2):103–9.

[17] Gerbert B, Bronstone A, Wolff M, Maurer T, Berger T, Pantilat S, McPhee SJ. Improving primary care residents’ proficiency in the diagnosis of skin cancer. J Gen Intern Med. 1998;13(2):91–7.

[18] Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen. 1996;3(1):47–53.

[19] Raasch BA, Hays R, Buettner PG: An educational intervention to improve diagnosis and management of suspicious skin lesions. J Contin Educ Health Prof. 2000;20(1):39–51.

[20] Westerhoff K, McCarthy WH, Menzies SW. Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol. 2000;143(5):1016–20.

[21] Youl PH, Raasch BA, Janda M, Aitken JF. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions. Clin Exp Dermatol. 2007;32(4):365–70.